Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
10/2008
10/09/2008US20080249135 Compounds for alzheimer's disease
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/08/2008EP1978021A1 Novel antibiotics
10/08/2008CN100424084C (Zinc) porphyrin - perylene diimide ( PDI) - C60 ternary system and its synthesis method
10/08/2008CN100424069C Process for production of 1-aryl-5-(trifluoromethyl)-1h- tetrazoles
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432072 Method of preventing wrong color formation of n-(carboxymethylaminocarbony)-4,4′-bis(dimethylamino) diphenylamine sodium, reagent solution for the method, and measurement method employing the method
10/02/2008WO2008119028A1 Alkenyldiarylmethanes having nitrogen-containing carboxylic acid derivatives
10/02/2008WO2007069271A3 Process for the purification of (s) -n- (l-carboxy-2-methyl-prop-1-yl) -n-pentanoyl-n- [2' - (1h-tetraz0l-5-yl) bipheny l-4 -ylmethyl] -amine (valsartan)
10/02/2008US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080241873 Multi-use multimodal imaging chelates
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
09/2008
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/25/2008US20080234490 Metal Salts of 2' - (1H-Tetrazol-5Yl) -1. 1'-Biphenyl-4-Carboxaldehyde
09/24/2008EP1465877B1 Positive-working photoimageable bottom antireflective coating
09/24/2008CN101270097A Process for production of 1-aryl-5-(trifluoromethyl)-1H-tetrazoles
09/24/2008CN101270096A Method for synthesizing diovan
09/23/2008US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/18/2008WO2008087656A3 Process for the preparation of unsymmetrically substituted biphenyl compounds
09/18/2008US20080227961 Chelation compounds, radionuclides
09/18/2008US20080227683 Compounds Having Antitumor Activity
09/17/2008CN101268065A Process for preparing an angiotensin II receptor antagonist
09/17/2008CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands
09/17/2008CN101265239A Amorphous form of valsartan
09/17/2008CN100418957C Synthesis of tris n-alkylated 1,4,7,10-tetraazacyclododecanes
09/16/2008US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/11/2008US20080221325 And sulfonated poly(aryl ether ketone) monomers; crosslinked with barbituric acid; fuel cells, seawater desalination, heavy water and sewage treatment and biomass-energy resources; improved water holding capacity, chemical resistance, electrochemical stability and heat resistance
09/10/2008EP1965805A1 Urea derivatives useful as calcium receptor modulators
09/10/2008EP1301474B1 Tyrosine derivatives as phosphatase inhibitors
09/10/2008CN101262867A MAO-B inhibitors useful for treating obesity
09/10/2008CN101260084A Production technique for preparing 5-alkyltetranitrozole by high pressure method
09/09/2008US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents
09/09/2008CA2353680C Process for the production of cyclene
09/09/2008CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof
09/04/2008WO2008105505A1 Bis-(1(2)h-tetrazol-5-yl)amine compound, reaction intermediate and their production methods
09/04/2008WO2008105473A1 Anti-malignant-tumor agent
09/04/2008WO2008104994A2 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
09/04/2008US20080214830 Angiotensin II receptor antagonist; industrially viable, recoverable and reusable; Irbesartan
09/04/2008US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1
09/04/2008US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist
09/04/2008US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid
09/04/2008CA2679185A1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
09/03/2008EP1963259A2 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
09/03/2008EP1261349B1 Compounds with chelation affinity and selectivity for first transition series elements and their use
09/03/2008CN101255141A Production technique for preparing 5-methyl tetrazole by high pressure method
08/2008
08/28/2008WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/27/2008EP1961746A1 Phthalamide derivative, agricultural or horticultural pesticide, and use of the pesticide
08/27/2008EP1960393A1 Multimeric magentic resonance contrast agents
08/27/2008EP1313714B1 Valsartan salts
08/27/2008CN101253131A Method for isolating 5-substituted tetrazoles
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/27/2008CN100413853C Synthetic intermediate of Irbesartan, preparation method and use thereof
08/27/2008CN100413852C Valsartan salts
08/26/2008US7417022 Amino acid for deliverying active materials; bioavailability
08/21/2008US20080200688 Explosive complexes
08/21/2008US20080200687 Preparation of Terazole Derivatives
08/21/2008US20080200552 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
08/21/2008US20080200551 Flourene Derivative
08/21/2008US20080200518 insecticides, acaricides; crops, foods and goods; a urea, a thiourea or a guanidine; ring is imidazole or 1,2,4-triazole or tetrazole; 4-{4-[4-(3,3-Dichloroprop-2-enyloxy)-2,6-dichlorophenoxy]butyl}-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazolin-5-one; a 1,2,3,4-tetrazolin-5-one
08/20/2008EP1957459A2 Iminopropene compound and use thereof
08/19/2008US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
08/19/2008US7414065 Methods to modulate conditions mediated by the CXCR4 receptor
08/19/2008CA2294609C Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
08/14/2008WO2008097459A2 Dual-acting antihypertensive agents
08/14/2008US20080194660 Angiotensin II receptor antagonists
08/13/2008CN101239943A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239942A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239935A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239930A Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl-1,3-diazaspirol[4,4]-non-ene-4-one
08/13/2008CN100409844C Noval compound, its synthetizing process and therapeutic use
08/12/2008US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/07/2008WO2008063287A3 Novel imidazothiazoles and imidazoxazoles
08/07/2008US20080188533 Dual-acting antihypertensive agents
08/07/2008US20080188532 Indole Compound and Use Thereof
08/07/2008US20080188423 Pi-3 kinase inhibitor prodrugs
08/07/2008US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction
08/06/2008EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders
08/06/2008EP1409024B1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
08/06/2008EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
08/06/2008CN100408539C Vitamin d receptor modulators
08/05/2008US7408078 Anthranilic acid derivatives useful in treating infection with hepatitis C virus
08/05/2008US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
07/2008
07/31/2008WO2008092120A1 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
07/31/2008US20080181847 kit of imaging probe, e.g.substituted triphenyl phosphine-paramagnetic metal(tetraazacyclododecane) complex; and targeting probe comprises the at least one azide group
07/30/2008EP1950204A1 Amorphous form of valsartan
07/30/2008CN101230046A Method for catalytic synthesis of 5-substituted tetrazole by tungstate
07/30/2008CN100406007C Asthma and allergic inflammation modulators
07/29/2008US7405332 making a fluoro radioactive material [18F]Fluorohaloalkanes radiotracer through halogenation, or solid phase synthesis; use in positron emission tomography (PET) studies
07/29/2008US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/29/2008CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
07/24/2008WO2008087656A2 Process for the preparation of unsymmetrically substituted biphenyl compounds
07/24/2008WO2008087177A1 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
07/24/2008WO2008086733A1 New pharmaceutical composition
07/24/2008US20080176821 phosphoryl-di(glutamate dibenzylester or dihydroxyamide) derivatives; neuroleptic agent, neurodegenerative diseases, neuropathic pain, epilepsy, ischaemia, schizophrenia, amyotrophic lateral sclerosis, Alzheimer's, Parkinson, Huntington diseases;
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 97